Revive Pro Care (AXIL) Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization

Public company logo of AXIL Brands, Inc. (AXIL)

AXIL Brands, Inc. (AXIL) is expanding its premium dermocosmetics segment through online channels and retail, integrating AI into its promotional strategies. The brand is valued for synthesizing medical protocols with comfortable skincare. The market trend on GURU.Markets based on the EV/EBITDA metric stands at 9.10. The localization of production facilities in the US guarantees business stability, eliminating the impact of external trade conflicts on future performance.

AXIL Brands Inc - AXIL Total Company Value to Operating Income Before Depreciation Ratio (period 11/23/2025 - 11/10/2026)

Metric breakdowns and analytics for reviveprocare.com (AXIL)

- market price and analyst price targets:
Price Chart AXIL Brands|AXIL - Analyst Median Target
- market capitalization details:
Market Value Revive Pro Care|AXIL - Enterprise Value
- book value of equity indicators:
Book Value per Share AXIL Brands|AXIL - Book Valuation of Business|Market Value to Book Value Ratio reviveprocare.com|AXIL - Total Business Assets
- issuer credit burden and liquidity indicators:
Total Debt to Capital AXIL Brands, Inc.|AXIL - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio AXIL Brands|AXIL - Company Aggregate Debt|Debts to Book Capitalization Revive Pro Care|AXIL - Long-Term Debt Volume|Company Short-Term Debt AXIL Brands|Quick Liquidity Indicator reviveprocare.com
- financial results and valuation multiples details:
AXIL - Final Profit|Projected Future Earnings AXIL Brands, Inc.|AXIL - Price to Earnings Ratio|Future Price to Earnings AXIL Brands|AXIL - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Revive Pro Care|AXIL - Operating profit EBITDA|Earnings per share for the last twelve months AXIL Brands|AXIL - Earnings per share for the last 12 months|Quarterly EPS earnings growth reviveprocare.com|AXIL - Earnings per share growth this year|Net earnings per share growth forecast for next year AXIL Brands, Inc.
Fundamental company valuation:Revive Pro Care AXIL
Product sample of AXIL Brands Inc

This multiple compares the total enterprise value, including net debt, with operating profit before depreciation and amortization, allowing for an objective asset valuation independent of the tax burden. Analyzing the EV/EBITDA dynamics of AXIL Brands, Inc. (AXIL) helps investors identify share overvaluation in a timely manner, which is critical for AXIL Brands, Inc. (AXIL) as it scales the premium Reputation brand based on high consumer confidence in the effectiveness of its formulas.

Analysis of competing companies

Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Krystal Corp KRYS|Total Company Value to Operating Income Before Depreciation Ratio Apogee Corp (APGE)|ARQT - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|VCEL - EV/EBITDA Multiple|ORKA: EV/EBITDA Multiple|SMTI - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization DBV Tech|Enterprise Value to Operating Income Before Depreciation SLSN (Solesence Inc.)|EV/EBITDA Multiple DERM|EV/EBITDA Multiple fortebiorx.com (FBRX)|Empro Group - Enterprise Value to EBITDA Ratio|SLGL: Enterprise Value to Operating Income Before Depreciation|Medicus Pharma Limited - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio Verrica Pharmaceuticals VRCA|hoththerapeutics.com (HOTH) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|BFRI (Biofrontera) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio VYNE|SNOA: Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple QNRX|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization AZTR (Azitra Corporation)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Dermata Therapeutics DRMA|Business Value to Operating Income Before Depreciation ELAB|Revance Therapeutics, Inc. - EV/EBITDA Multiple